
### [NCIT:C8420](http://purl.obolibrary.org/obo/NCIT_C8420)
**Label:** Diffuse Malignant Mesothelioma

**Subclasses:** [NCIT:C6747](http://purl.obolibrary.org/obo/NCIT_C6747) (Desmoplastic Mesothelioma), [NCIT:C7985](http://purl.obolibrary.org/obo/NCIT_C7985) (Epithelioid Mesothelioma), [NCIT:C45663](http://purl.obolibrary.org/obo/NCIT_C45663) (Pleural Sarcomatoid Mesothelioma), [NCIT:C45662](http://purl.obolibrary.org/obo/NCIT_C45662) (Pleural Epithelioid Mesothelioma), [NCIT:C45665](http://purl.obolibrary.org/obo/NCIT_C45665) (Pleural Biphasic Mesothelioma), [NCIT:C45664](http://purl.obolibrary.org/obo/NCIT_C45664) (Pleural Desmoplastic Mesothelioma), [NCIT:C4282](http://purl.obolibrary.org/obo/NCIT_C4282) (Biphasic Mesothelioma), [NCIT:C45655](http://purl.obolibrary.org/obo/NCIT_C45655) (Sarcomatoid Mesothelioma), 

**Class expressions from DL-Learner:**

- Thing 52.26%
- [NCIT:C41605](http://purl.obolibrary.org/obo/NCIT_C41605) (Neoplastic Mesothelial Cell) 44.12%
- [NCIT:C36829](http://purl.obolibrary.org/obo/NCIT_C36829) (Abnormal Mesothelial Cell) 44.12%
- [NCIT:C36831](http://purl.obolibrary.org/obo/NCIT_C36831) (Malignant Mesothelial Cell) 41.61%
- [NCIT:C12917](http://purl.obolibrary.org/obo/NCIT_C12917) (Malignant Cell) and [NCIT:C41605](http://purl.obolibrary.org/obo/NCIT_C41605) (Neoplastic Mesothelial Cell) 41.61%
- [NCIT:C36831](http://purl.obolibrary.org/obo/NCIT_C36831) (Malignant Mesothelial Cell) and (not ([NCIT:C4008](http://purl.obolibrary.org/obo/NCIT_C4008) (Recurrent Gallbladder Carcinoma))) 41.61%
- [NCIT:C36831](http://purl.obolibrary.org/obo/NCIT_C36831) (Malignant Mesothelial Cell) and (not ([NCIT:C40079](http://purl.obolibrary.org/obo/NCIT_C40079) (Ovarian Clear Cell Adenocarcinofibroma))) 41.61%
- [NCIT:C36831](http://purl.obolibrary.org/obo/NCIT_C36831) (Malignant Mesothelial Cell) and (not ([NCIT:C40075](http://purl.obolibrary.org/obo/NCIT_C40075) (Ovarian Endometrioid Cystadenoma))) 41.61%
- [NCIT:C36831](http://purl.obolibrary.org/obo/NCIT_C36831) (Malignant Mesothelial Cell) and (not ([NCIT:C40066](http://purl.obolibrary.org/obo/NCIT_C40066) (Undifferentiated Ovarian Sarcoma))) 41.61%
- [NCIT:C36831](http://purl.obolibrary.org/obo/NCIT_C36831) (Malignant Mesothelial Cell) and (not ([NCIT:C40063](http://purl.obolibrary.org/obo/NCIT_C40063) (Ovarian Low Grade Endometrioid Stromal Sarcoma))) 41.61%
- [NCIT:C36831](http://purl.obolibrary.org/obo/NCIT_C36831) (Malignant Mesothelial Cell) and (not ([NCIT:C40061](http://purl.obolibrary.org/obo/NCIT_C40061) (Ovarian Endometrioid Adenocarcinoma with Squamous Differentiation))) 41.61%
- [NCIT:C36831](http://purl.obolibrary.org/obo/NCIT_C36831) (Malignant Mesothelial Cell) and (not ([NCIT:C40043](http://purl.obolibrary.org/obo/NCIT_C40043) (Ovarian Mucinous Cystic Tumor Associated with Pseudomyxoma Peritonei))) 41.61%
- [NCIT:C36831](http://purl.obolibrary.org/obo/NCIT_C36831) (Malignant Mesothelial Cell) and (not ([NCIT:C40041](http://purl.obolibrary.org/obo/NCIT_C40041) (Ovarian Mucinous Cystadenofibroma))) 41.61%
- [NCIT:C36831](http://purl.obolibrary.org/obo/NCIT_C36831) (Malignant Mesothelial Cell) and (not ([NCIT:C40034](http://purl.obolibrary.org/obo/NCIT_C40034) (Ovarian Mucinous Adenocarcinofibroma))) 41.61%
- [NCIT:C36831](http://purl.obolibrary.org/obo/NCIT_C36831) (Malignant Mesothelial Cell) and (not ([NCIT:C40032](http://purl.obolibrary.org/obo/NCIT_C40032) (Ovarian Serous Cystadenofibroma))) 41.61%


